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This study examines the association between social
deprivation and patient characteristics and outcomes
in a nationally representative cohort of incident renal
replacement therapy (RRT) patients. All Caucasian patients
reported to the UK Renal Registry between 1997 and 2004 by
centers in England and Wales with high data completeness
were included. Social deprivation was assessed using the
Townsend index. Socially deprived patients were more likely
to be referred late. They were less likely to receive peritoneal
dialysis (25.1 vs 34.8% on day 1, P trend o0.0001) or a renal
transplant (5.3 vs 12.4% at 1 year, P trend o0.0001), and
were less likely to attain UK Renal Association standards
for hemoglobin and phosphate at 1 year. Crude survival
decreased significantly with increasing deprivation for
patients under the age of 65 years, but not for those aged 65
years and above (likelihood ratio for age–social deprivation
interaction Po0.0001). Social deprivation was significantly
associated with poorer survival after adjustment for age,
gender, and cause of renal failure. After adjusting for baseline
co-morbidity, social deprivation was no longer associated
with poorer survival. Baseline differences in co-morbidity
seem to explain poorer crude survival in incident Caucasian
RRT patients from socially deprived areas in England and
Wales. Differences also exist in some processes of care and
intermediate outcomes, which may be amenable to
intervention.
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Assuring quality of care for patients with kidney disease has
been central to initiatives such as Kidney Disease Outcomes
Quality Initiative1 and the European Best Practice Guide-
lines2 and is a key role of national and international renal
registries. Quality assurance requires not only an under-
standing of the socio-demographic factors that affect patient
outcomes but also an appreciation of the extent to which
these factors are the result of suboptimal or inequitable
delivery of care.
An association between low socio-economic status and
poorer survival on renal replacement therapy (RRT) has been
reported in the United States of America (USA) for some
time,3,4 with evidence implicating personal and environ-
mental factors, such as health-related behavior and social
stratification in communities, rather than financial or
structural barriers to care.4 However, after separating Black
and Caucasian patients in their analysis of incident patients
in Michigan, Port et al.3 found no trend for increased
mortality in Caucasian patients according to income. The
interaction between ethnicity and social deprivation may be
even more complex, with one report suggesting that affluent
ethnic minority patients may actually have poorer outcomes
on RRT than their more socially deprived counterparts
(Kimmel et al., J Am Soc Nephrol, 2000; 11: 1236A. Abstract).
The relationship between social deprivation and non-renal
chronic diseases, such as cardiovascular disease and diabetes,
also appears to differ importantly between Caucasian and
South Asian populations.5
Outside the USA, the association between social depriva-
tion and survival on RRT has been little studied, with results
from the United Kingdom (UK) inconsistent (Junor. The
Renal Association; P35 15, 16 April 2003. Abstract), (Trehan
et al., Nephrol Dial Transplant 18 (suppl 4); 204, 2003.
Abstract).6 Although RRT is available in both countries
irrespective of ability to pay, considerable differences exist in
population coverage and access to health care in the general
population,7 and therefore during the predialysis phase, the
effects of which may persist once on RRT.
The aim of this paper is to examine the association
between social deprivation and patient characteristics in a
nationally representative cohort of incident RRT patients and
to study what independent effect social deprivation has on
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RRT outcomes. This has been restricted to Caucasians to
avoid any confounding by ethnic status. The relationship
between ethnicity and outcomes in incident RRT patients in
the UK has been studied separately.8
RESULTS
Baseline characteristics
The cohort of 10 392 patients had a median (interquartile
range) age of 65.1 (51.3–74.2) years and 62.1% were male.
Diabetic nephropathy was the cause of end-stage renal disease
in 17.3% patients (Table 1). The distribution of patients
was fairly equal across the social deprivation quintiles
(19.2–21.5%) (Table 1). Patients in the more deprived
quintiles were younger and more likely to be female than
those in the more affluent quintiles (Table 1). There were
significant differences in primary renal diagnoses across the
social deprivation quintiles, with diabetic nephropathy and
renal vascular disease more frequently coded in the more
deprived groups whereas polycystic kidney disease, uncertain
and ‘other’ were less frequently observed in these groups.
Immediately before commencing RRT, patients in the more
deprived groups had lower mean hemoglobin values and
slightly higher systolic blood pressure and estimated
glomerular filtration rate than those in the more affluent
groups, although serum phosphate and diastolic blood
pressure did not differ (Table 1).
Co-morbidity and late referral
In the subset of patients from centers with data completeness
for co-morbidity, current smoking was more frequently
reported in the more deprived groups whereas malignancy
was more frequently reported in more affluent patients. No
other differences in co-morbidity were observed between the
deprivation quintiles (Table 2). In the subset of patients from
centers with data completeness for late referral, both age
groups (18–64 and 65þ years) showed evidence that those
from more socially deprived areas were more likely to be
referred late than those from more affluent areas (Table 2).
Modality of treatment
At initiation of RRT, 61.9% of patients were receiving hemo-
dialysis, 34.8% peritoneal dialysis, and 3.3% had a pre-emptive
Table 1 | Patient characteristics at initiation of RRT
Total
Deprivation group, %
P-value
n (%) 1 2 3 4 5 v2
Townsend data 10 392 19.2 20.7 19.3 21.5 19.2
Age (median) (years) 65.1 66.0 65.9 65.3 64.8 62.9 o0.0001a
o0.0001b
Gender (male) 6458 (62.1) 64.0 62.5 62.6 62.2 59.4 0.045
o0.005c
Primary renal disease
Diabetes 1733 (17.3) 13.8 14.9 17.5 19.6 20.8 o0.0001
o0.0001c
GN 1304 (13.0) 13.2 14.1 13.2 12.9 11.7 NS
NSc
Polycystic 752 (7.5) 8.7 7.8 7.8 6.9 6.4 NS
o0.005c
Pyelonephritis 935 (9.3) 9.0 9.0 9.7 9.2 9.8 NS
NSc
Renal vasc dis. 1528 (15.3) 14.4 14.9 14.3 16.3 16.3 NS
o0.05c
Other 1629 (16.3) 18.8 17.1 15.3 15.8 14.5 o0.005
o0.0005c
Uncertain 2122 (21.2) 22.1 22.2 22.2 19.3 20.5 NS
o0.05c
Laboratory variables (mean)
eGFR9 (median) (ml/min/1.73m2) 7305 7.3 7.3 7.1 7.5 7.3 o0.05a
o0.05b
Hb (g/l) 6647 10.1 10.0 10.0 10.0 9.9 NSa
o0.01b
Phos (mmol/l) 8520 1.6 1.7 1.7 1.7 1.7 NSa
NSb
Blood pressure
SBP (mmHg) 4673 140.8 142.0 143.4 143.0 144.0 NSa
o0.05b
DBP (mmHg) 4673 77.0 77.0 77.8 76.7 76.7 NSa
NSb
DBP, diastolic blood pressure; eGFR, estimated GFR; GN, glomerulonephritis; Hb, hemoglobin; NS, not significant; Phos, phosphate; Renal vasc dis., renal vascular disease;
RRT, renal replacement therapy; SBP, systolic blood pressure.
Social deprivation group 1=least deprived, 5=most deprived.
aKruskal–Wallis test.
bLinear regression.
cCochran–Armitage trend test.
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renal transplant (Table 3). A lower proportion of patients in the
more deprived quintiles received peritoneal dialysis as their first
treatment and, although not common in any group, pre-
emptive renal transplantation occurred less than half as
frequently in the most deprived quintile compared with the
most affluent quintile (Table 3). By 90 days, the proportion of
patients on peritoneal dialysis or with a renal transplant had
increased considerably more in the most affluent quintile than
in the most deprived quintile (Table 3).
Treatment and treatment-related outcomes at 1 year
One year after the initiation of RRT, lower rates of
transplantation were still observed in the patients from more
deprived areas (Table 3). There was no consistent pattern to
the contribution of live and cadaver kidneys across the
groups (data not shown). In the fourth quarter of RRT,
patients from more deprived areas were less likely to attain
the UK Renal Association (UKRA) standard for hemoglobin
and phosphate. No difference was observed in attaining the
urea reduction ratio, systolic, or diastolic blood pressure
standards (Table 3).
Survival: age–social deprivation interaction and multivariate
analysis
Two crude Cox’s proportional hazards (CPH) models were
fitted, one including age and social deprivation and the other
including age, social deprivation, and an age–social depriva-
tion interaction term. The likelihood ratio test between these
two models yielded a P-value of o0.0001, suggesting a
significant interaction between age and social deprivation.
Exploring this in Kaplan–Meier analyses, no clear differences
in crude survival are observed for over 65 s in the
Kaplan–Meier analysis, whereas survival is significantly lower
in the more deprived quintiles in the adults under the age of
65 years (Figure 1).
In the baseline CPH model (including only social
deprivation), incident RRT patients from more socially
deprived areas have a significantly higher hazard ratio than
those in the reference group (patients from least deprived
areas) (hazard ratio for patients from the most deprived areas
(relative to those from the most affluent areas)¼ 1.20, 95%
confidence interval: 1.07–1.35) (Table 4). This difference
becomes more significant when the younger age of the more
deprived patients is taken into account and remains
significant after adjusting for the higher proportion of
females and the higher rates of diabetic nephropathy and
renal vascular disease among the more socially deprived
(Table 4). Once co-morbidity is added to the model,
however, not only does the association become nonsignifi-
cant, but the hazard ratios change considerably (e.g. for Dep
5, from 1.26 (1.12–1.42) in step 4 to 0.86 (0.65–1.15) in step
5) (Table 4).
DISCUSSION
In this large, multicentre cohort of incident Caucasian RRT
patients, social deprivation was associated with poorer
patient survival over a median follow-up of nearly 2 years
until differences in baseline co-morbidity were adjusted for.
Differences were observed, however, in clinical parameters at
the start of RRT, the use of peritoneal dialysis and
transplantation, and in attainment of some UKRA standards
after 1 year of RRT.
This is the first large national study primarily looking at
the relationship between social deprivation and outcome on
RRT outside the USA. Data have been collected within the
strict quality assurance framework of the UKRR and further
optimized by setting data completeness requirements while
maintaining a cohort that is comparable to the Registry
cohort as a whole (with the exception that ethnic minorities
were excluded). Any effect of ethnicity was removed by
restricting analysis to Caucasians.
Although this study has found no association, after
adjusting for co-morbidity accrued before developing end-
stage renal disease, between living in a socially deprived area
and reduced survival on RRT, it does not exclude the
possibility that individual poverty influences survival; such
individual-level data are not collected by the UKRR.
Outcome analysis was restricted to survival, as no routine
morbidity data, such as hospitalization or quality of life, are
available.
After 1 year of RRT, patients from more deprived areas
remained less likely to attain the UKRA standard for
Table 2 | Co-morbidity and late referral according to social
deprivation in subgroups with data completeness at center
level of 85%
Deprivation group, %
P-value
1 2 3 4 5 v2
Co-morbidity, n=2468 446 507 492 553 470
Smoking 13.6 13.4 16.5 20.4 24.4 o0.0001
o0.0001a
Diabetes 6.3 8.6 6.2 8.7 7.1 NS
NSa
Vascular disease
Angina 16.1 20.0 21.6 22.1 17.7 NS
NSa
MI43 mo 9.5 12.3 11.2 13.6 8.8 NSa
NS
Stroke 11.0 12.5 12.4 11.2 9.9 NSa
NS
Malignancy 17.3 16.8 12.2 12.3 12.2 o0.05
o0.005a
Late referral
Patients 18–64, n=1988 351 353 391 471 422
o90 days 19.4 26.4 23.0 26.8 25.1 o0.005
o0.01a
90–365 days 21.1 15.9 16.6 17.8 25.4
4365 days 59.5 57.8 60.4 55.4 49.5
Patients 65+, n=1832 383 393 356 376 324
o90 days (%) 33.4 30.0 33.4 38.0 37.0 NS
90–365 days (%) 16.2 19.9 22.8 20.7 18.2 o0.001a
4365 days (%) 50.4 50.1 43.8 41.2 44.8
NS, not significant.
Social deprivation group 1=least deprived, 5=most deprived. MI43 mo=myocardial
infarction more than 3 months ago.
aTrend probability calculated by fitting linear regression.
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hemoglobin of 410 g/dl and phosphate of o1.8 mmol/l,
despite equivalent dialysis adequacy as measured by urea
reduction ratio. The same observation was made by Trehan
(Nephrol Dial Transplant 18 (Suppl 4); 204, 2003. Abstract).
These differences in attainment of UKRA standards are
unadjusted for differences in case mix and are therefore
consistent with the differences in crude survival. There is,
however, no evidence that improving hemoglobin levels is
associated with reduced mortality (reviewed by Renal
Association10). Further, interpreting associations between
hemoglobin data and survival in observational studies is
fraught with difficulty: is the low hemoglobin cause or effect?
No data are available in the UKRR data set on compliance,
which is believed to be more of a problem in patients from
more deprived areas,11 but is not likely to play a major role in
the UK – data from the Dialysis Outcomes and Practice
Patterns Study have suggested that non-compliance with
fluid restrictions in the UK is one-third of the Euro-Dialysis
Outcomes and Practice Patterns Study average with only
0.8% of patients in the UK skipping one or more dialysis
sessions per month12 compared with 8.5% in the USA.13
Differences in transplantation rates do not explain the
differences in hemoglobin target attainment, as the results
were unchanged when the analysis was repeated with
transplanted patients excluded.
The lower transplantation rates in patients from more
socially deprived areas are consistent with the observations in
Scotland14 and the USA.15 Late referral may be partly
responsible, but the differences persist 1 year after initiation
of RRT and, following patients through the transplant work-
up, Kasiske15 found socially deprived patients had an equal
chance of receiving a transplant once they made it onto the
waiting list. In this study, the more socially deprived did not
appear to have higher levels of co-morbidity which would
Table 3 | Treatment modality (at start, day 90, and 1 year) and attainment of standards10 in the fourth quarter after starting
RRT
Deprivation group, %
P-value
Total n (%) 1 2 3 4 5 v2
Treatment at start
HD 6984 (67.3) 61.9 63.1 66.9 70.7 73.7 o0.0001
o0.0001a
PD 3165 (30.5) 34.8 34.2 31.1 27.4 25.1 o0.0001
o0.0001a
Transplant 233 (2.2) 3.3 2.7 2.0 2.0 1.3 o0.0005
o0.0001a
Treatment at day 90b
HD 5492 (61.0) 54.0 56.3 61.0 64.3 69.3 o0.00001
o0.00001a
PD 3223 (35.8) 41.2 39.6 36.2 32.9 29.1 o0.0001
o0.0001a
Transplant 289 (3.2) 4.8 4.1 2.8 2.8 1.6 o0.0001
o0.0001a
Treatment at 1 yearc
HD 3763 (57.0) 48.2 53.1 57.6 60.4 66.0 o0.0001
o0.0001a
PD 2255 (34.1) 39.5 36.6 34.1 31.7 28.7 o0.0001
o0.0001a
Transplant 586 (8.9) 12.4 10.3 8.3 7.9 5.3 o0.0001
o0.0001a
Percentage achieving UKRA standards at one year
Hb (410 g/dl) 7434 (71.5) 81.9 79.2 79.5 78.2 74.4 o0.0001
o0.0001a
URRd (465%) 2995 (79.6) 61.5 61.9 59.1 58.3 57.2 NS
NSa
Phosph (o1.8 mmol/l) 7354 (70.8) 65.4 63.0 61.2 61.9 59.8 o0.05
o0.005a
Blood pressure at 1 yeare
SBP (o130 mmHg) 4553 (43.8) 35.7 37.9 37.7 36.5 38.6 NS
NSa
DBP (o80 mmHg) 4553 (43.8) 56.6 59.7 60.6 58.6 59.0 NS
NSa
Hb, hemoglobin; HD, hemodialysis; DBP, diastolic blood pressure; PD, peritoneal dialysis; Ref, reference variable; Phos, phosphate; RRT, renal replacement therapy;
SBP, systolic blood pressure; URR, urea reduction ratio; UKRA, UK Renal Association.
Social deprivation group 1=least deprived, 5=most deprived.
aCochrane–Armitage trend test.
bExcluding 860 patients who died and 68 transferred out of reporting centers or stopped treatment by day 90, three lost to follow-up and 457 on RRT o90 days.
cExcluding 1766 patients who died and 80 transferred out of reporting centers or stopped treatment by 1 year, two lost to follow-up and 1940 on RRT o1 year.
dHD patients only.
ePost-dialysis blood pressure for HD patients.
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deem them unfit for transplantation – smoking rates were
higher, as were rates of diabetes as the cause of end-stage
renal disease, but the patients were younger. Renal trans-
plantation from living donors appears consistent across the
social deprivation spectrum and is therefore unlikely to
explain the differences in overall transplantation rates. The
issue of access to renal transplantation is currently the subject
of a collaborative study between the UKRR and UK
transplant.
Given the higher mortality rates observed among more
socially deprived individuals in the UK general population,16
the poorer crude survival of incident RRT patients from
more socially deprived areas observed in this study is
intuitive. The effect of social deprivation on crude survival
incorporates all the co-morbidity accrued before RRT by
living in a socially deprived area as well as the effect of social
deprivation on survival once on RRT. Similar differences in
crude survival on RRT were reported in Scotland by Junor
(The Renal Association; P35, 15, 16 April 2003. Abstract), who
described poorer crude survival in those under 55 years of
age from socially deprived areas but not in those over 55
years. Two studies from the North of England, however, have
found no association between area level deprivation and
survival (Trehan et al., Nephrol Dial Transplant 18 (Suppl 4);
204, 2003. Abstract).6 Neither study adjusted for co-
morbidity. In the USA, two large studies have examined
social deprivation and survival in dialysis patients.3,4
Although overall there was a significant negative association
between social deprivation and survival, no association was
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Figure 1 | Kaplan–Meier survival plot stratified by age and social
deprivation. Interaction between age and social deprivation
examined using likelihood ratio test.
Table 4 | Multivariable associations between patient characteristics and mortality
CPH model, hazard ratios (95% CI) (n=9046)
Variables (U)
Step 1
Soc dep only Step 2+age Step 3+gender Step 4+PRD Step 5+co-morb
Townsend index (n=9046)
Dep 1, most affluenta 1 1 1 1 1
Dep 2 0.97 (0.87–1.09) 0.97 (0.87–1.09) 0.97 (0.87–1.09) 1.00 (0.89–1.12) 0.83 (0.6–1.09)
Dep 3 1.06 (0.95–1.19) 1.04 (0.92–1.16) 1.03 (0.92–1.16) 1.05 (0.93–1.18) 0.80 (0.61–1.06)
Dep 4 1.11 (0.99–1.24) 1.12 (1.00–1.25) 1.12 (1.00–1.25) 1.12 (0.99–1.25) 1.00 (0.76–1.30)
Dep 5, most deprived 1.20* (1.07–1.35) 1.28* (1.14–1.44) 1.28* (1.14–1.43) 1.26* (1.12–1.42) 0.86 (0.65–1.15)
Independent variables:
Age (years) NA 1.05* (1.05–1.05) 1.05* (1.05–1.05) 1.05* (1.05–1.05) 1.04* (1.03–1.05)
Male gender NA NA 1.09* (1.01–1.17) 1.06 (0.99–1.15) 1.15 (0.95–1.38)
Primary renal diagnosis (n=8781)
GNa NA NA NA 1 1
Diabetes NA NA NA 2.43* (2.10–2.82) 1.88* (1.34–2.65)
Polycystic NA NA NA 0.65* (0.52–0.82) 0.63 (0.36–1.09)
Pyelonephritis NA NA NA 1.14 (0.95–1.36) 1.11 (0.73–1.68)
Renal vasc dis. NA NA NA 1.53* (1.31–1.78) 1.35 (0.96–1.89)
Other NA NA NA 2.23* (1.91–2.59) 2.62* (1.87–3.67)
Uncertain NA NA NA 1.39* (1.20–1.61) 1.11 (0.78–1.58)
Co-morbidity (n=1950)
Vascular disease NA NA NA NA 1.53* (1.27–1.85)
Current smoker NA NA NA NA 1.60* (1.28–1.99)
Malignancy NA NA NA NA 1.74* (1.40–2.16)
COPD NA NA NA NA 1.36* (1.03–1.80)
Diabetes NA NA NA NA 1.28 (0.95–1.72)
Liver disease NA NA NA NA 1.76* (1.02–3.04)
CI, confidence interval; COPD, chronic obstructive pulmonary disease; CPH, Cox’s proportional hazards; GN, glomerulonephritis; HD, hemodialysis; NA, not available;
PD, peritoneal dialysis; Renal vasc dis., renal vascular disease; Tx, transplant.
aReference category.
*Significant independent association with mortality beyond day 90.
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observed in the white subgroup analysis of either study. The
authors of the more recent of these studies proceeded to
adjust for 25 confounding variables (including co-morbidity)
and having done so, observed improved survival with
decreasing social deprivation (measured in terms of area-
level income).4 Given the higher levels of co-morbidity in
patients starting dialysis from more socially deprived areas,
this shift, which is counterintuitive from a co-morbidity
perspective, suggests that other factors among the 25 adjusted
for must be exerting a greater influence on survival in
the USA.
A further technical point worth consideration is the
approach taken to transplantation. Both US studies3,4 and the
O’Riordan study6 censored at transplantation, an approach
which, given the higher transplantation rate among the less
socially deprived, will preferentially remove patients with the
best prognosis from this group and reduce the chances of
finding an association between social deprivation and
outcome. After repeating the CPH model in the UKRR
cohort with patients censored at transplant, the hazard ratios
for the socially deprived quintiles were reduced in the early
steps of the model – as would be expected and in keeping
with the US data – but remained significant.
Adjusting for co-morbidity in this study resulted not only
in a widening and shifting of the 95% confidence intervals of
the hazard ratios to cross 1.00, but also a marked shifting in
the estimated hazard ratios for the social deprivation
quintiles so that they became less than 1.00. This suggests
that the effect of social deprivation on outcome is largely
confounded by baseline co-morbidities and smoking beha-
viour on RRT.
Conclusion
In keeping with the strong association between social
deprivation and mortality in the UK general population,
this study has found evidence of poorer survival among
Caucasian patients from socially deprived areas commencing
RRT in England and Wales. These differences in survival,
however, appear to be fully explained by higher levels of
baseline co-morbidity in this group compared with their
counterparts from more affluent areas. Differences in some
processes of care and intermediate health outcomes do,
however, exist and need to be targeted. Efforts should be
directed at understanding and intervening on the late referral
of younger patients from socially deprived areas and ensuring
equitable access to renal transplantation and attainment of
anemia standards of care.
As patients on RRT have regular contact with the medical
services, future research must consider the relationship
between individual- rather than area-level social deprivation
and outcomes. It is also important that all patients from
socially deprived areas have appropriate access to health care
in order to prevent chronic kidney disease, delay progression
of existing chronic kidney disease, manage their increased
cardiovascular risk, and facilitate their transition onto RRT.
MATERIALS AND METHODS
The UK Renal Association Renal Registry (UKRR) data collection
methods are described in detail elsewhere.8 In brief, a pre-defined
data set is sent electronically to the Registry from participating renal
units. Data items include baseline socio-demographic and clinical
data, time of referral, modes of treatment, date of death, and
baseline and three monthly biochemical and hematology tests. For
this analysis, data from the fourth quarter after initiation of RRT
have been taken to represent intermediate outcomes at 1 year. The
UKRR has approval from the Secretary of State through the Patient
Information Advisory Group to collect patient data without
individual patient consent.
Case definition and case ascertainment
All incident Caucasian patients starting RRT between 1 January
1997 and 31 December 2004 were included if they received their first
treatment in a renal unit in England or Wales that reported to the
UKRR with a high level of completeness of ethnicity recording
(X85%) during that year. (This latter requirement was applied in
order to maximize the quality of the data used in the analysis.)
A cumulative total of 32 of the 58 renal units in England and
Wales were included (128 center years), increasing from six in 1997
to 24 in 2004 (Table 5). They varied in geographical location and
size and included teaching and non-teaching hospitals. Twelve
thousand seven hundred and nine patients commenced RRT in
these units during years that they were included in the study – 55%
(12 709/23 109) of all incident patients reported to the Registry.
Eighty two percent (10 392/12 709) of these patients were coded
Caucasian and included in the study cohort. There were no
differences in the age or gender distributions in the patients
Table 5 | Patients and renal units included
1997 1998 1999 2000 2001 2002 2003 2004 Total
Units includeda/total
units participating in
Registry (%)
6/12
(50)
10/20
(50)
15/24
(63)
15/28
(54)
13/34
(38)
22/39
(56)
23/43
(53)
24/49
(49)
128/249
(51)
All patients in units
included/all incident
patients in Registry (%)
588/1028
(57)
999/1892
(53)
1362/2119
(64)
1370/2536
(54)
1400/3194
(44)
2175/3607
(60)
2366/4015
(59)
2449/4718
(52)
12709/23109
(55)
White patients in units
included/all patients
in units included (%)
435/588
(74)
829/999
(83)
1160/1362
(85)
1140/1370
(83)
1129/1400
(81)
1790/2175
(82)
1965/2366
(83)
1944/2449
(79)
10392/12709
(82)
aMore than 85% ethnicity returns in given year.
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included or excluded or in the frequency of diabetic nephropathy as
the cause of ESRD (data not shown). The primary renal diagnosis
was, however, more frequently missing in the excluded cohort
(primary renal diagnosis missing in 11.5% of excluded patients and
3.9% of included patients, Po0.0001). There was no difference in
survival between RRT patients in centers with X85% data
completeness and those in centers with o85% data completeness
(data not shown).
Some renal units upload ethnicity coding electronically from the
hospital patient administration systems, which use national coding
systems based on patient self-reported ethnicity.17 For the remaining
renal units, ethnic coding is by renal unit ascription rather than by
patient self-assessment. Only patients coded ‘White’ (i.e. Caucasian)
were included in the analysis for this study.
Social deprivation was measured using the Townsend Index
deprivation score. Each patient’s postcode of residence was matched
to the 2001 UK Census output area file. A Townsend Index
deprivation score was derived for each Census output area; this score
is based on the percentage of unemployed individuals and the
percentage of households that had no car, were overcrowded, and
were not owner occupier in each area.18 The postcodes were then
divided into five equal-sized population quintiles according to the
level of deprivation of the area in which they were in, with group 1
representing the least deprived patients and group 5 the most
deprived. For the 5% of postcodes, which crossed an output area
boundary and which therefore had more than one Townsend score,
the mean value was taken.
Intermediate outcomes were assessed against the UKRA
standards – hemoglobin 410 g/dl, urea reduction ratio 465%,
phosphate o1.8 mmol/l, and blood pressure o130/80.10
Follow-up for survival was to 31 December 2004 – a median
duration of 585 days, range 1–2914 days.
Subgroup analyses
Co-morbidity is assigned by renal unit staff using a standard UKRR
classification. These data items are not complete; only 2468 patients
commenced RRT in centers with both X85% completeness of
ethnicity data and co-morbidity data in the same year.
Late referral was defined as referral to the renal unit o90 days
before initiation of RRT; referral p1 year was also examined.
Similarly, data completeness requirements were defined (X85% for
ethnicity and late referral), which resulted in a cohort of 3820
patients.
Statistical analysis
Statistical analyses used standard tests for comparing groups (w2 and
Kruskal–Wallis test) and testing for trend (Cochrane–Armitage test
for trend and linear regression).
The primary outcome was all-cause mortality from 90 days after
initiation of RRT – mortality in the first 90 days of RRT is believed
to relate more to the definition of acute renal failure.8 Nine
thousand four of the 10 382 incident patients (86.7%) were alive on
RRT at 90 days and included in the survival analysis. The likelihood
ratio test between two crude CPH models – one including age and
social deprivation and the other including age, social deprivation,
and an age–social deprivation interaction term –was used to look for
an interaction between age and social deprivation. Kaplan–Meier
plots were used to show crude survival according to age and social
deprivation quintile. CPH modelling was then used to explore the
independent effect of social deprivation. Patients were not censored
at transplantation. In the subset of patients from units with more
complete data, the effect of adding co-morbidity to the survival
model was investigated.
The assumption of proportionality was assessed by graphical
methods (Nelson–Aalen plots) and the final models by Schoenfield
residuals.
All statistical analyses were performed using SAS software.
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